Regulator finds ‘concerning' evidence of poor handling of insurance claims
The regulator said that, while rising motor insurance premiums are largely driven by external cost pressures, shortcomings persist in how some insurers handle claims.
FCA analysis indicated that increases in the cost of motor claims – due to higher prices for cars, parts, labour, energy and more complex cars and supply chains – have contributed to premium increases.
The cost of hire vehicles, the number and cost of theft claims and uninsured drivers have also risen significantly. This confirms that increased costs outside of firms' control, rather than firm profit, were the biggest cause of recent premium rises in motor insurance.
But the FCA did identify that referral fees from credit hire firms and claims management companies were associated with slower claims processing and increasing costs.
Where it has seen poor practice from firms, the regulator said it is addressing it directly with them, including taking action against specific firms where necessary.
The regulator said that 'concerning' evidence of poor claims handling practices included a lack of oversight of outsourced services, resulting in poor customer outcomes, delays in settling claims and high complaint volumes.
It also found evidence of insufficient management information, resulting in failures to promptly identify and resolve claims handling issues.
Cash settlements were also being used in some cases without sufficient consideration of whether they are most suitable, the regulator said.
The FCA also highlighted high rejection rates for storm damage claims, saying only 32% of such claims made to a sample of firms in 2024 resulted in a payment.
The regulator is also providing evidence for coordinated action from Government, industry, and other regulators, as part of the Government's motor taskforce, to help drive down the cost of motor premiums. This could help limit cost increases but it cannot prevent them, the FCA said.
It has also published an interim update of an ongoing premium finance market study investigating whether consumers receive fair value when choosing to pay for insurance in monthly instalments.
While premium finance allows customers to spread costs, making them affordable and providing flexibility, the regulator has found some firms earn much more money than it costs to provide the service. It will explore these concerns further in the next phase of the study.
The FCA said it will seek to tackle any issues it finds first through the Consumer Duty, publishing a final report by the end of 2025.
Sarah Pritchard, deputy chief executive of the FCA, said: 'Insurance provides peace of mind but people must be confident they can get a fair deal and be treated right when the worst happens.
'External cost pressures are primarily to blame for recent motor premium increases, not increased firm profits, but there is some more work to do on claims handling, particularly in home and travel. That's why we're stepping up – making sure claims are handled promptly and fairly and pushing for a coordinated effort to tackle the root causes of rising motor premiums.
'A well-functioning insurance market helps consumers navigate their financial lives and supports growth by building people's resilience to financial and personal shocks.'
The FCA also said that evaluation of previous pricing reforms showed they are having the intended impact on the price gap between new and existing customers in both the motor and home markets.
This means its reforms were effective in curbing 'price walking' where loyal customers were charged more at renewal, the regulator said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Apple, Google Under Fire: UK Regulators Launch Bold Crackdown on Browser Monopoly
July 23 Britain's Competition and Markets Authority plans to designate Apple (NASDAQ:AAPL) and Google (NASDAQ:GOOGL) with strategic market status over their mobile ecosystems. The CMA's inquiry found markets relating to mobile internet browsers were not working well for consumers or businesses. Apple's Safari and Google's Chrome together dominate browsing on iPhones and Android handsets. A strategic market status designation would allow the CMA to impose interventions requiring firms to follow specific behaviours to protect fair competition. CMA chief Sarah Cardell said the measures would help UK app developers remain at the forefront of innovation and ensure users receive a world?class experience. The regulator highlighted opportunities for more innovation and choice. A final decision is due by Oct. 22, with roadmaps published for potential next steps. Google's senior director for competition, Oliver Bethell, called the move disappointing and unwarranted and warned against rules that could impede growth in the UK. Apple said it was concerned the proposed steps might undermine the privacy and security protections users expect. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 minutes ago
- Yahoo
ImmunityBio's (IBRX) ANKTIVA Gets Approved by UK's Medicines and Healthcare Regulatory Agency
ImmunityBio, Inc. (NASDAQ:IBRX) is one of the . On July 8, ImmunityBio, Inc. (NASDAQ:IBRX) announced that the UK's Medicines and Healthcare products Regulatory Agency has approved ANKTIVA with Bacillus Calmette-Guérin for treating certain bladder cancer patients. This is significant as it marks the first approval for the company outside of the United States of America. Moreover, the drug is a first-in-class IL-15 agonist, which works by activating and multiplying immune cells, specifically NK cells and T cells that help the body fight cancer. A technician analyzing natural killer cells, as part of an immune system study and research into therapeutical agents. In addition, clinical studies have shown strong results as some patients maintained a complete response for over 47 months at the last review. ImmunityBio, Inc. (NASDAQ:IBRX) is a biopharmaceutical company that develops therapies and vaccines that boost the immune system to fight cancer and infectious diseases. While we acknowledge the potential of IBRX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


TechCrunch
4 minutes ago
- TechCrunch
UK targets Apple and Google's mobile platforms for regulation
In Brief The U.K.'s Competition and Markets Authority (CMA) announced on Wednesday a proposal that would give Apple and Google's mobile platforms 'strategic market status' — a designation that allows the regulator to create rules that could change how their app stores operate and how their mobile software works. The move is designed to create a more open, competitive environment for the app economy and user choice. However, Apple and Google have pushed back at the proposals, with Apple saying changes would compromise user security and privacy. A final decision on the matter will arrive in October, after the two companies present their cases. If the proposal goes through, it would give the CMA the ability to address issues like the commission rates on in-app purchases, the app review process, app rankings, restrictions on developer access to certain technology, and default settings that could reduce competition, among other things. Tim Sweeney, CEO of Epic Games, which has been involved in antitrust lawsuits against the tech giants, expressed his disappointment in the proposed roadmap, as it doesn't allow for competing mobile app stores like the Epic Games Store.